Norges Bank Burning Rock Biotech LTD Transaction History

Norges Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.15 - $3.16 $601,920 - $884,683	-279,963 Closed	0 $0
Q2 2022 Aug 14, 2023	BUY	$1.75 - $10.44 $489,935 - $2.92 Million	279,963 New	279,963 $814,000
Q1 2022 May 12, 2023	BUY	$6.7 - $10.23 $1.88 Million - $2.86 Million	279,963 New	279,963 $2.6 Million
Q3 2021 Nov 14, 2022	BUY	$17.37 - $27.92 $2.61 Million - $4.19 Million	150,127 New	150,127 $2.68 Million
Q2 2021 Aug 10, 2021	SELL	$26.14 - $37.45 $522,800 - $749,000	-20,000 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$23.5 - $39.58 $470,000 - $791,600	20,000 New	20,000 $538,000
Q1 2021 May 07, 2021	SELL	$23.5 - $39.58 $470,000 - $791,600	-20,000 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$22.55 - $30.87 $451,000 - $617,400	20,000 New	20,000 $462,000
Q4 2020 Feb 10, 2021	SELL	$22.55 - $30.87 $451,000 - $617,400	-20,000 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$19.07 - $29.61 $381,400 - $592,200	20,000 New	20,000 $502,000
Q3 2020 Nov 10, 2020	SELL	$19.07 - $29.61 $381,400 - $592,200	-20,000 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$23.21 - $31.43 $464,200 - $628,600	20,000 New	20,000 $540,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $642M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.